FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Theravance Biopharma, Inc.: capex

One fact, its scope and the complete path back to the official record.

Period: 2015-01-01 – 2015-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/fc133458-7ece-466a-affa-327c83c9f816

Reported value

$657.000k{"amount": 657000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
Theravance Biopharma, Inc.
Metric
capex
Period
2015-01-01 – 2015-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001104659-15-037749 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T16:09:21.476876+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001583107/capex/2015-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.